Go back to News
NEWS
Gómez-Acebo & Pombo advises on the Atrys takeover bid, deal of the month for TTR
8 of June, 2021
According to TTR’s Monthly Report for Spain, the Spanish M&A market recorded a 13% increase 0 in the first five months of 2021, a period in which Gómez-Acebo & Pombo has also played a key role as the prestigious platform has selected the acquisition of 99.75% of ASPY by the Spanish company Atrys Health, through a takeover bid. Gómez-Acebo & Pombo advised this transaction, which amounted to approximately EUR 223.27m, on the legal side.
Click here to read the full article
Click here to read the full article
Press contact
Director of Business Development, Marketing and Communications
Director of Business Development, Marketing and Communications
More information about
Gómez-Acebo & Pombo
5 days ago 
PUBLICATION
16 Apr, 2025
Pharma & Healthcare No. 43
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
16 Apr, 2025 
PUBLICATION
27 Mar, 2025
The notion of ‘pharmacological action’ in the legal concept of medicinal product
A look at the judgment of the Court of Justice in Case C-589/23, Cassella-med and MCM Klosterfrau, ECLI:EU:C:2025:173.
27 Mar, 2025
PUBLICATION
25 Mar, 2025
A first ranking mortgage does not prevent a creditor from accelerating loan maturity due to debtor insolvency
If the creditor has a secured claim (even if the debt is covered by the "value of the security", i.e. the claim is in the money), the debtor cannot avoid the effects of the to-term forfeiture by appealing to the existence of that security because the guarantee referred to in Article 1129(1) of the Civil Code (avoiding to-term forfeiture) must then be another additional guarantee.
25 Mar, 2025
PUBLICATION
25 Mar, 2025
La existencia de una hipoteca de primer rango no impide que el acreedor pueda declarar el vencimiento anticipado del plazo por insolvencia sobrevenida del deudor
Si el acreedor goza de una garantía real para la seguridad de su crédito (incluso si la deuda está cubierta por el «valor de la garantía», es decir, que el crédito está in the money), el deudor no puede evitar los efectos de la pérdida del plazo apelando a la existencia de aquella garantía real porque la garantía a que se refiere el artículo 1129.1.º del Código Civil (evitadora de la pérdida del plazo) deberá ser entonces otra garantía suplementaria.
25 Mar, 2025
PUBLICATION
14 Mar, 2025
A good ruling on financial assistance: collateral given to secure third-party borrowings is not invalid
This latest Supreme Court ruling on the prohibition of financial assistance in the purchase of shares in the assisting company (assisting as ‘borrower for third party debt’) is to be praised, erasing the bad taste left by the reading of the immediate precedent (Supreme Court Judgment of 20 April 2023, Ezentis) which held an agreement to underwrite the value of the shares sold by the company invalid.
14 Mar, 2025
PUBLICATION
10 Mar, 2025
Pharma & Healthcare No. 42
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
10 Mar, 2025
PUBLICATION
07 Feb, 2025
New obligation to make health data available to third parties: issues with protected data
This paper explores the new obligation to make health data available to third parties in light of the Regulation of the European Parliament and of the Council on the European Health Data Space.
07 Feb, 2025
PUBLICATION
29 Jan, 2025
Medidas y prórroga de medidas laborales y de seguridad social a la espera de los Presupuestos Generales del Estado
Ante la ausencia de Presupuestos Generales del Estado, se aprueban medidas urgentes que, en el ámbito laboral y de la Seguridad Social, permiten actualizar algunas cuantías y aplicar algunas normas previstas para el 2025.
29 Jan, 2025
PUBLICATION
29 Jan, 2025
La nueva obligación de poner datos de salud a disposición de terceros: problemática cuando los datos están protegidos
Se examina la nueva obligación de poner datos de salud a disposición de terceros a la luz del Reglamento del Parlamento Europeo y del Consejo relativo al Espacio Europeo de Datos de Salud.
29 Jan, 2025